scholarly article | Q13442814 |
P356 | DOI | 10.1086/506354 |
P698 | PubMed publication ID | 16886144 |
P2093 | author name string | Fiona Smaill | |
Marek Smieja | |||
Christine Lee | |||
Danny Lagrotteria | |||
Serena Holmes | |||
P433 | issue | 5 | |
P921 | main subject | diarrhea | Q40878 |
metronidazole | Q169569 | ||
Clostridium difficile | Q310543 | ||
rifampicin | Q422652 | ||
P304 | page(s) | 547-552 | |
P577 | publication date | 2006-07-25 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea | |
P478 | volume | 43 |
Q42063601 | Analysis of anti-Clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and actagardine, both singly and in paired combinations |
Q24234378 | Antibiotic treatment for Clostridium difficile -associated diarrhea in adults |
Q24244302 | Antibiotic treatment for Clostridium difficile-associated diarrhea in adults |
Q30235446 | Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults |
Q83025404 | Can metronidazole still be used for treatment of Clostridium difficile infections? |
Q56225357 | Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) |
Q37633859 | Clinical update for the diagnosis and treatment of Clostridium difficile infection |
Q38445227 | Clostridium Difficile Infection from a Surgical Perspective. |
Q35208564 | Clostridium difficile Infection and Inflammatory Bowel Disease: A Review. |
Q37305032 | Clostridium difficile infection in the intensive care unit |
Q24632641 | Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance |
Q36757577 | Clostridium difficile-associated disease: changing epidemiology and implications for management |
Q36871148 | Clostridium difficile: The evolving story |
Q38538221 | Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection |
Q41832378 | Current Treatment Options for Severe Clostridium difficile-associated Disease |
Q26786662 | Efficacy and Safety of Metronidazole Monotherapy versus Vancomycin Monotherapy or Combination Therapy in Patients with Clostridium difficile Infection: A Systematic Review and Meta-Analysis |
Q35164536 | Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections |
Q47577721 | Measurement of selected preventable adverse drug events in electronic health records: Toward developing a complexity score |
Q45325656 | National epidemiology of initial and recurrent Clostridium difficile infection in the Veterans Health Administration from 2003 to 2014. |
Q37052819 | New advances in the treatment of Clostridium difficile infection (CDI) |
Q34602195 | New antimicrobial agents for patients with Clostridium difficile infections |
Q55405974 | Novel Antimicrobials for the Treatment of Clostridium difficile Infection. |
Q36098158 | On Lactococcus lactis UL719 competitivity and nisin (Nisaplin(®)) capacity to inhibit Clostridium difficile in a model of human colon |
Q37875055 | Recurrent Clostridium difficile infection: what are the treatment options? |
Q85170619 | Rifampin plus Metronidazole for Clostridium difficile Infection |
Q43168261 | The A, B, BI, and Cs of Clostridium difficile |
Q28082059 | The potential for emerging therapeutic options for Clostridium difficile infection |
Q36270659 | Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination |
Q37050248 | Update on the changing epidemiology of Clostridium difficile-associated disease |
Q30417830 | Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice |
Search more.